Description
Identification of therapeutically relevant gene mutations for Cancer
Multiplex Ligation-Dependent Probe Amplification (MLPA) Analysis
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
255%
GERMLINE BRCA 1 AND 2 – LAL PATH LAB
Panel of BRCA1&2 Genes
-
264%
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
-
260%
IGVH Somatic Hyper Mutation Assay
Colon and Lung Cancer marker
Reviews
There are no reviews yet.